HP inks catheter deal with Guidant

Article

Hewlett-Packard has signed an agreement with Guidant of Indianapolisgiving that cardiology device company rights to distribute coronaryand peripheral intravascular ultrasound catheters that HP haslicensed from Boston Scientific. HP executed the deal

Hewlett-Packard has signed an agreement with Guidant of Indianapolisgiving that cardiology device company rights to distribute coronaryand peripheral intravascular ultrasound catheters that HP haslicensed from Boston Scientific. HP executed the deal becauseit believes that Guidant's distribution channels are more suitedfor the IVUS market than its own, according to the Andover, MA,company.

HP gained access to the catheters through an agreement lastyear with Boston Scientific, which at the time was preparing tobuy catheter developers Cardiovascular Imaging Systems and ScimedLife Systems. To avoid a monopoly in the IVUS market, the FederalTrade Commission required Boston Scientific to enter a consentdecree in which it licensed the technology to a third party, Hewlett-Packard(SCAN 3/15/95).

HP already has a deal with Guidant for development of guideddirectional atherectomy catheters. Guidant also has rights todistribute Hewlett-Packard's Sonos Intravascular Ultrasound Systemwith the catheters.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.